Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer
US-10010552-B2 · Jul 3, 2018 · US
Kovats Steven was listed as an assignee on 1 patent publication in 2018.
| Metric | Value |
|---|---|
| Company | Kovats Steven |
| Year | 2018 |
| Patents | 1 |
Representative publications for Kovats Steven in 2018.
Most common classification codes for Kovats Steven in 2018.
| CPC | Patents |
|---|---|
| A61K2300/00 | 1 |
| A61K31/4439 | 1 |
| A61K31/497 | 1 |
| A61K31/519 | 1 |
| A61K31/535 | 1 |
Navigate to parent entity pages.